633 related articles for article (PubMed ID: 34977870)
1. Tumor metastasis: Mechanistic insights and therapeutic interventions.
Liu M; Yang J; Xu B; Zhang X
MedComm (2020); 2021 Dec; 2(4):587-617. PubMed ID: 34977870
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.
Talbot LJ; Bhattacharya SD; Kuo PC
Int J Biochem Mol Biol; 2012; 3(2):117-36. PubMed ID: 22773954
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications.
Hochheuser C; Windt LJ; Kunze NY; de Vos DL; Tytgat GAM; Voermans C; Timmerman I
Stem Cells Dev; 2021 Jan; 30(2):59-78. PubMed ID: 33287630
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention.
Baba SK; Baba SK; Mir R; Elfaki I; Algehainy N; Ullah MF; Barnawi J; Altemani FH; Alanazi M; Mustafa SK; Masoodi T; Akil ASA; Bhat AA; Macha MA
Front Cell Dev Biol; 2023; 11():1164301. PubMed ID: 37384249
[TBL] [Abstract][Full Text] [Related]
6. Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.
Nepali PR; Kyprianou N
Front Endocrinol (Lausanne); 2023; 14():1160267. PubMed ID: 37091854
[TBL] [Abstract][Full Text] [Related]
7. Cancer metastasis: Molecular mechanisms and clinical perspectives.
Khan SU; Fatima K; Malik F; Kalkavan H; Wani A
Pharmacol Ther; 2023 Oct; 250():108522. PubMed ID: 37661054
[TBL] [Abstract][Full Text] [Related]
8. Anoikis resistance: an essential prerequisite for tumor metastasis.
Kim YN; Koo KH; Sung JY; Yun UJ; Kim H
Int J Cell Biol; 2012; 2012():306879. PubMed ID: 22505926
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
10. Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics.
Kalita B; Coumar MS
Cell Oncol (Dordr); 2021 Aug; 44(4):751-775. PubMed ID: 33914273
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis.
Hipólito A; Martins F; Mendes C; Lopes-Coelho F; Serpa J
Front Oncol; 2021; 11():656851. PubMed ID: 34150624
[TBL] [Abstract][Full Text] [Related]
12. The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights.
Joshi VB; Gutierrez Ruiz OL; Razidlo GL
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046830
[TBL] [Abstract][Full Text] [Related]
13. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
Begemann D; Anastos H; Kyprianou N
Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
[TBL] [Abstract][Full Text] [Related]
14. Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between "seed and soil".
Wu J; Long Y; Li M; He Q
Acta Pharm Sin B; 2021 Aug; 11(8):2286-2305. PubMed ID: 34522588
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
16. Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection.
Patel SA; Dave MA; Murthy RG; Helmy KY; Rameshwar P
Oncol Rev; 2011 Jun; 5(2):93-102. PubMed ID: 21776337
[TBL] [Abstract][Full Text] [Related]
17. Molecular principles of metastasis: a hallmark of cancer revisited.
Fares J; Fares MY; Khachfe HH; Salhab HA; Fares Y
Signal Transduct Target Ther; 2020 Mar; 5(1):28. PubMed ID: 32296047
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential.
Lin Z; Wu Y; Xu Y; Li G; Li Z; Liu T
Mol Cancer; 2022 Sep; 21(1):179. PubMed ID: 36100944
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
20. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
